Improve multiple myeloma diagnosis investigations by implementing clinical decision support tools - Massachusetts General Hospital

26 Sept 2025

In this case study, Binding Site presents the advantages of integrating Clinical Decision Support (CDS) tools into the diagnostic investigation process for multiple myeloma, drawn from the successful implementation of guideline-based sFLC suggestive alerts at Massachusetts General Hospital, US.

Optilite® Freelite® Assays

Binding Site

Detect and monitor Multiple Myeloma (MM) with Freelite® assays. The time-tested and proven solution for kappa and lambda serum free light chain (sFLC) analysis

(0)

Links

Tags